Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells
- PMID: 3040658
- DOI: 10.1093/jac/20.1.61
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells
Abstract
The luminol-enhanced chemiluminescence (CL) assay was used to examine the effects of antifungal agents tested at concentrations above and below therapeutically achievable levels on the CL response of mouse spleen cells. Reduction in the CL response of phagocytic cells may be indicative of an inhibition of the cellular immune response. Concomitantly, an increase in the CL response of phagocytic cells may indicate an enhancement of the immune capacity of these cells. The effects of four antifungal agents, bifonazole, fluconazole (UK-49,858), itraconazole, and terbinafine were studied. Changes in the CL response were assessed in terms of peak intensity, time to peak intensity, and area under the intensity-time curve compared with appropriate diluent controls for each drug. Both bifonazole and itraconazole caused significant reduction in peak CL intensity only at the highest level assayed (20 mg/l). Fluconazole had no significant effect on the CL response of mouse spleen cells at levels up to 20 mg/l, inclusive. Although terbinafine had no significant effect on peak CL intensity, it did cause a significant decrease in time to peak response at levels above 5 mg/l. This decrease in time to peak response may be indicative of an enhancement in the immune capacity of the mouse spleen cells; the clinical significance of this observation remains to be determined.
Similar articles
-
Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.Antimicrob Agents Chemother. 1986 Apr;29(4):602-7. doi: 10.1128/AAC.29.4.602. Antimicrob Agents Chemother. 1986. PMID: 3707108 Free PMC article.
-
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.Br J Clin Pharmacol. 1991 Nov;32(5):624-6. doi: 10.1111/j.1365-2125.1991.tb03963.x. Br J Clin Pharmacol. 1991. PMID: 1659439 Free PMC article.
-
Azoles, allylamines and drug metabolism.Br J Dermatol. 1992 Feb;126 Suppl 39:14-8. doi: 10.1111/j.1365-2133.1992.tb00003.x. Br J Dermatol. 1992. PMID: 1311943
-
New oral treatments for dermatophytosis.Ann N Y Acad Sci. 1988;544:580-5. doi: 10.1111/j.1749-6632.1988.tb40456.x. Ann N Y Acad Sci. 1988. PMID: 2850758 Review. No abstract available.
-
Pharmacokinetic optimisation of oral antifungal therapy.Clin Pharmacokinet. 1993 Oct;25(4):329-41. doi: 10.2165/00003088-199325040-00006. Clin Pharmacokinet. 1993. PMID: 8261715 Review.
Cited by
-
Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.Drugs. 1989 Mar;37(3):310-44. doi: 10.2165/00003495-198937030-00003. Drugs. 1989. PMID: 2540949 Review.
-
Effect of fluconazole on phagocytic response of polymorphonuclear leukocytes in a rat model of acute sepsis.Mediators Inflamm. 2005 Feb 24;2005(1):9-15. doi: 10.1155/MI.2005.9. Mediators Inflamm. 2005. PMID: 15770061 Free PMC article.
-
Severe asthma with fungal sensitization.Curr Allergy Asthma Rep. 2011 Oct;11(5):403-13. doi: 10.1007/s11882-011-0217-4. Curr Allergy Asthma Rep. 2011. PMID: 21789577 Review.
-
Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.Antimicrob Agents Chemother. 1994 Nov;38(11):2605-11. doi: 10.1128/AAC.38.11.2605. Antimicrob Agents Chemother. 1994. PMID: 7872755 Free PMC article.
-
Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.Drugs. 1992 Feb;43(2):259-84. doi: 10.2165/00003495-199243020-00010. Drugs. 1992. PMID: 1372222 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources